Novartis AG Market Cap 2006-2018 | NVS

Historical market capitalization for Novartis AG (NVS) over the last 10 years. The current market cap for Novartis AG (NVS) as of June 30, 2018 is $190.66B.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $92.695B $49.109B
Novartis AG is committed to improving health and well-being through innovative products and services. The company aspires to capture and hold a leadership position in all of their businesses with a strong, sustainable performance based on continuous innovation. Their long-term success is founded on meeting the expectations of all our stakeholders - their customers, their people, their shareholders and the communities in which they live and work.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $337.643B 16.13
Pfizer (PFE) United States $222.220B 13.67
Merck (MRK) United States $168.566B 15.07
AbbVie (ABBV) United States $141.090B 14.39
Novo Nordisk (NVO) Denmark $123.252B 20.42
Sanofi (SNY) France $106.218B 13.44
GlaxoSmithKline (GSK) United Kingdom $103.814B 14.19
Eli Lilly (LLY) United States $96.028B 19.07
AstraZeneca (AZN) United Kingdom $94.148B 9.86
Bristol-Myers Squibb (BMY) United States $92.695B 18.23